Smith Anglin Financial »

Cns Pharmaceuticals shares owned by Smith Anglin Financial

Quarter-by-quarter ownership of Cns Pharmaceuticals (CNSP) shares owned by Smith Anglin Financial from 13F filings

Historical chart of Smith Anglin Financial investment in Cns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cns Pharmaceuticals held by Smith Anglin Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cns Pharmaceuticals by Smith Anglin Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $33k 90k 0.36
2023-12-31 $64k 50k 1.27

More positions owned by Smith Anglin Financial

Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p500 Etf (IVV)
John Hancock Exchange Traded Multifactor Mi (JHMM)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr S&p 500 Val Etf (IVE)
American Centy Etf Tr Us Eqt Etf (AVUS)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Ishares Tr Core Div Grwth (DGRO)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)

View all positions for Smith Anglin Financial

Top funds holding Cns Pharmaceuticals

Smith Anglin Financial
Vanguard Group
Virtu Financial
Wells Fargo & Company
Global Retirement Partners
Bank of America Corporation
Plante Moran Financial Advisors

View all funds holding Cns Pharmaceuticals